Novartis Ag NVS
NYSE NVS
$145.70 -1.18 (-0.80%)
As of: Sep 29, 2026 · 3:59 PM EDT

Novartis Ag (NVS) Restructuring Costs (2024 - 2025)

Updated

Novartis Ag (NVS) reported Restructuring Costs of $544 million for Q4 2025, up 11.7% from $487 million a year earlier.

Analysis

Novartis Ag (NVS) Restructuring Costs (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Bristol Myers Squibb 130.49 Bn 81.76 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 544.00 Mn
Dec 31, 2024 487.00 Mn
API Access

Novartis Ag Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=NVS&period=max&api_key=YOUR_API_KEY